# US 2004/0063186 A1 · Vectors and methods for recombinant protein expression

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0063186 A1
- Document ID: US20040063186A1
- Status: Published application
- Kind: A1
- Application number: 10/683,775
- Filed: 2003-10-10
- Published: 2004-04-01
- Earliest claimed: 1999-10-13
- Assignees: Immunex Corporation
- Inventors: Jeffrey T. McGrew
- Web page: https://patentgrep.com/patent/US20040063186A1

## CPC

- C12N 15/67: General methods for enhancing the expression
- C07K 14/7155: {for interleukins [IL]}
- C12N 15/85: for animal cells
- C12N 2840/203: having an IRES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

There is disclosed an expression vector utilizing an internal polyadenylation signal. The internal polyadenylation signal is inserted between a DNA encoding a protein of interest and a DNA encoding a selectable marker, and allows a single promoter to generate both monocistronic messages and dicistronic messages. Similar, multicistronic vectors can also be prepared. Also disclosed are methods of using the expression vector utilizing an internal polyadenylation signal, host cells transfected therewith, stable pools of cells transfected with an expression vector utilizing an internal polyadenylation signal, and clones of such transfected cells.

## Claims

### Claim 1

An expression vector comprising, in the following order, a promoter sequence, a first coding sequence, a polyadenylation site, and a second coding sequence, wherein no promoter sequence occurs between the internal polyadenylation site and the second coding sequence.

### Claim 2 (depends on 1)

The expression vector of claim 1, wherein the second coding sequence encodes a selectable marker.

### Claim 3 (depends on 2)

The expression vector of claim 2, wherein the selectable marker is dihydrofolate reductase.

### Claim 4 (depends on 1)

The expression vector of claim 1 wherein the internal polyadenylation site is selected from the group consisting of SV40 late polyadenylation site (SEQ ID NO:1), SV40 early polyadenylation site (SEQ ID NO:3), and a mutant SV40 late polyadenylation site consisting essentially of nucleotides 80 through 222 of SEQ ID NO:1.

### Claim 5 (depends on 2)

The expression vector of claim 2 wherein the internal polyadenylation site is selected from the group consisting of SV40 late polyadenylation site (SEQ ID NO:1), SV40 early polyadenylation site (SEQ ID NO:3), and a mutant SV40 late polyadenylation site consisting essentially of nucleotides 80 through 222 of SEQ ID NO:1.

### Claim 6 (depends on 3)

The expression vector of claim 3 wherein the internal polyadenylation site is selected from the group consisting of SV40 late polyadenylation site (SEQ ID NO:1), SV40 early polyadenylation site (SEQ ID NO:3), and a mutant SV40 late polyadenylation site consisting essentially of nucleotides 80 through 222 of SEQ ID NO:1.

### Claim 7 (depends on 1)

The expression vector of claim 1 wherein an internal ribosome entry site (IRES) is inserted between the DNA encoding the internal polyadenylation site and the DNA encoding the selectable marker such that the IRES is operably linked to the selectable marker.

### Claim 8 (depends on 2)

The expression vector of claim 2 wherein an internal ribosome entry site (IRES) is inserted between the DNA encoding the internal polyadenylation site and the DNA encoding the selectable marker such that the IRES is operably linked to the selectable marker.

### Claim 9 (depends on 3)

The expression vector of claim 3 wherein an internal ribosome entry site (IRES) is inserted between the DNA encoding the internal polyadenylation site and the DNA encoding the selectable marker such that the IRES is operably linked to the selectable marker.

### Claim 10 (depends on 4)

The expression vector of claim 4 wherein an internal ribosome entry site (IRES) is inserted between the DNA encoding the internal polyadenylation site and the DNA encoding the selectable marker such that the IRES is operably linked to the selectable marker.

### Claim 11 (depends on 5)

The expression vector of claim 5 wherein an internal ribosome entry site (IRES) is inserted between the DNA encoding the internal polyadenylation site and the DNA encoding the selectable marker such that the IRES is operably linked to the selectable marker.

### Claim 12 (depends on 6)

The expression vector of claim 6 wherein an internal ribosome entry site (IRES) is inserted between the DNA encoding the internal polyadenylation site and the DNA encoding the selectable marker such that the IRES is operably linked to the selectable marker.

### Claim 13 (depends on 7)

A stable pools of cells transfected with an expression vector according to claim 7.

### Claim 14 (depends on 8)

A stable pools of cells transfected with an expression vector according to claim 8.

### Claim 15 (depends on 9)

A stable pools of cells transfected with an expression vector according to claim 9.

### Claim 16 (depends on 10)

A stable pools of cells transfected with an expression vector according to claim 10.

### Claim 17 (depends on 11)

A stable pools of cells transfected with an expression vector according to claim 11.

### Claim 18 (depends on 12)

A stable pools of cells transfected with an expression vector according to claim 12.

### Claim 19 (depends on 13)

A cell line cloned from the pool of claim 13.

### Claim 20 (depends on 14)

A cell line cloned from the pool of claim 14.

### Claim 21 (depends on 15)

A cell line cloned from the pool of claim 15.

### Claim 22 (depends on 16)

A cell line cloned from the pool of claim 16.

### Claim 23 (depends on 17)

A cell line cloned from the pool of claim 17.

### Claim 24 (depends on 18)

A cell line cloned from the pool of claim 18.

### Claim 25 (depends on 13)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 13 under conditions promoting expression of the protein, and recovering the protein.

### Claim 26 (depends on 14)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 14 under conditions promoting expression of the protein, and recovering the protein.

### Claim 27 (depends on 15)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 15 under conditions promoting expression of the protein, and recovering the protein.

### Claim 28 (depends on 16)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 16 under conditions promoting expression of the protein, and recovering the protein.

### Claim 29 (depends on 17)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 17 under conditions promoting expression of the protein, and recovering the protein.

### Claim 30 (depends on 18)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 18 under conditions promoting expression of the protein, and recovering the protein.

### Claim 31 (depends on 19)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 19 under conditions promoting expression of the protein, and recovering the protein.

### Claim 32 (depends on 20)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 20 under conditions promoting expression of the protein, and recovering the protein.

### Claim 33 (depends on 21)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 21 under conditions promoting expression of the protein, and recovering the protein.

### Claim 34 (depends on 22)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 22 under conditions promoting expression of the protein, and recovering the protein.

### Claim 35 (depends on 23)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 23 under conditions promoting expression of the protein, and recovering the protein.

### Claim 36 (depends on 24)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 24 under conditions promoting expression of the protein, and recovering the protein.

### Claim 37 (depends on 1)

The expression vector of claim 1, which further comprises a second polyadenylation site following the second coding sequence and operably linked thereto.

### Claim 38

An expression vector comprising, in the following order, a promoter sequence, a first coding sequence, a polyadenylation site consisting essentially of nucleotides 80 through 222 of SEQ ID NO:1, and a second coding sequence, wherein no promoter sequence occurs between the internal polyadenylation site and the second coding sequence.

### Claim 39 (depends on 38)

A stable pool of mammalian cells transfected with an expression vector according to claim 38.

### Claim 40 (depends on 39)

A cell line cloned from the pool of claim 39.

### Claim 41 (depends on 39)

A method for obtaining a recombinant protein, comprising culturing a stable pool of cells according to claim 39 under conditions promoting expression of the protein, and recovering the protein.

### Claim 42 (depends on 40)

A method for obtaining a recombinant protein, comprising culturing a cell line according to claim 40 under conditions promoting expression of the protein, and recovering the protein.

### Claim 43 (depends on 7)

A mammalian host cell containing an expression vector according to claim 7.

### Claim 44 (depends on 8)

A mammalian host cell containing an expression vector according to claim 8.

### Claim 45 (depends on 9)

A mammalian host cell containing an expression vector according to claim 9.

### Claim 46 (depends on 10)

A mammalian host cell containing an expression vector according to claim 10.

### Claim 47 (depends on 11)

A mammalian host cell containing an expression vector according to claim 11.

### Claim 48 (depends on 36)

A mammalian host cell containing an expression vector according to claim 36.

### Claim 49 (depends on 38)

The expression vector of claim 38, which further comprises a second polyadenylation site following the second coding sequence and operably linked thereto.
